Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Abnormalities, Drug-Induced | 28 | 2024 | 341 | 5.020 |
Why?
|
Anticonvulsants | 30 | 2024 | 1923 | 4.000 |
Why?
|
Limb Deformities, Congenital | 10 | 2022 | 136 | 3.970 |
Why?
|
Polydactyly | 6 | 2023 | 57 | 3.100 |
Why?
|
Congenital Abnormalities | 13 | 2019 | 708 | 3.030 |
Why?
|
Abnormalities, Multiple | 13 | 2022 | 1424 | 2.850 |
Why?
|
Phenytoin | 10 | 2024 | 190 | 2.730 |
Why?
|
Teratogens | 12 | 2021 | 117 | 2.430 |
Why?
|
Fingers | 11 | 2024 | 511 | 2.310 |
Why?
|
Amniotic Band Syndrome | 4 | 2022 | 22 | 2.230 |
Why?
|
Phenobarbital | 8 | 2024 | 192 | 1.830 |
Why?
|
Prenatal Exposure Delayed Effects | 14 | 2024 | 2538 | 1.800 |
Why?
|
Toes | 6 | 2022 | 209 | 1.620 |
Why?
|
Carbamazepine | 7 | 2024 | 224 | 1.540 |
Why?
|
Pregnancy | 74 | 2024 | 30179 | 1.440 |
Why?
|
Hand Deformities, Congenital | 3 | 2022 | 175 | 1.380 |
Why?
|
Epilepsy | 18 | 2024 | 3324 | 1.280 |
Why?
|
Registries | 19 | 2024 | 8373 | 1.270 |
Why?
|
Chorionic Villi Sampling | 4 | 2014 | 35 | 1.080 |
Why?
|
Valproic Acid | 6 | 2023 | 443 | 1.070 |
Why?
|
Prenatal Diagnosis | 9 | 2018 | 1274 | 1.020 |
Why?
|
Fetus | 9 | 2022 | 1883 | 1.020 |
Why?
|
Hypospadias | 2 | 2017 | 97 | 1.000 |
Why?
|
Infant, Newborn | 43 | 2022 | 26395 | 0.970 |
Why?
|
Chromosome Aberrations | 5 | 2018 | 1781 | 0.910 |
Why?
|
Pallister-Hall Syndrome | 1 | 2023 | 4 | 0.890 |
Why?
|
Musculoskeletal Abnormalities | 1 | 2023 | 101 | 0.830 |
Why?
|
Teratology | 2 | 2020 | 8 | 0.820 |
Why?
|
Hypothalamic Diseases | 2 | 2023 | 134 | 0.810 |
Why?
|
Syndactyly | 2 | 2022 | 75 | 0.810 |
Why?
|
Finger Phalanges | 1 | 2022 | 41 | 0.800 |
Why?
|
Maternal Exposure | 8 | 2018 | 1078 | 0.780 |
Why?
|
Anencephaly | 2 | 2018 | 20 | 0.760 |
Why?
|
Hamartoma | 2 | 2023 | 236 | 0.750 |
Why?
|
Pregnancy Complications | 15 | 2024 | 2969 | 0.740 |
Why?
|
Hip Dislocation, Congenital | 2 | 2014 | 225 | 0.730 |
Why?
|
Abortion, Spontaneous | 3 | 2023 | 539 | 0.710 |
Why?
|
Neural Tube Defects | 2 | 2019 | 255 | 0.640 |
Why?
|
Foot Deformities, Congenital | 2 | 2018 | 59 | 0.640 |
Why?
|
Face | 4 | 2021 | 1031 | 0.610 |
Why?
|
Foramen Magnum | 1 | 2018 | 41 | 0.590 |
Why?
|
Double Outlet Right Ventricle | 1 | 2018 | 60 | 0.590 |
Why?
|
Ectromelia | 2 | 2009 | 28 | 0.590 |
Why?
|
Pregnancy in Diabetics | 2 | 2018 | 198 | 0.570 |
Why?
|
Genes, X-Linked | 1 | 2018 | 128 | 0.570 |
Why?
|
Triazines | 3 | 2016 | 312 | 0.540 |
Why?
|
Abortion, Eugenic | 1 | 2016 | 39 | 0.530 |
Why?
|
Triploidy | 1 | 2016 | 3 | 0.530 |
Why?
|
General Adaptation Syndrome | 1 | 2016 | 7 | 0.530 |
Why?
|
Female | 87 | 2024 | 396943 | 0.510 |
Why?
|
Stillbirth | 2 | 2019 | 376 | 0.500 |
Why?
|
Urethra | 1 | 2017 | 406 | 0.490 |
Why?
|
Genes, Recessive | 1 | 2018 | 625 | 0.490 |
Why?
|
Genes, Dominant | 2 | 2009 | 856 | 0.480 |
Why?
|
Physical Examination | 1 | 2021 | 1262 | 0.480 |
Why?
|
Infant | 17 | 2024 | 36497 | 0.460 |
Why?
|
Regional Blood Flow | 1 | 2018 | 1502 | 0.460 |
Why?
|
Anti-Retroviral Agents | 3 | 2019 | 1794 | 0.460 |
Why?
|
Clubfoot | 1 | 2014 | 87 | 0.450 |
Why?
|
Fructose | 2 | 2014 | 285 | 0.440 |
Why?
|
Penis | 1 | 2014 | 213 | 0.440 |
Why?
|
Fetal Growth Retardation | 2 | 2017 | 585 | 0.440 |
Why?
|
Hydatidiform Mole | 1 | 2016 | 255 | 0.440 |
Why?
|
Delayed Diagnosis | 1 | 2017 | 469 | 0.430 |
Why?
|
Neck | 1 | 2018 | 736 | 0.420 |
Why?
|
Anus, Imperforate | 1 | 2013 | 63 | 0.410 |
Why?
|
Birth Weight | 3 | 2017 | 2117 | 0.410 |
Why?
|
Heterocyclic Compounds, 3-Ring | 3 | 2021 | 295 | 0.410 |
Why?
|
Vascular Malformations | 1 | 2018 | 469 | 0.400 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2015 | 477 | 0.400 |
Why?
|
Pubic Bone | 1 | 2011 | 31 | 0.390 |
Why?
|
Ectodermal Dysplasia | 1 | 2013 | 107 | 0.390 |
Why?
|
Humans | 96 | 2024 | 768451 | 0.390 |
Why?
|
Cyclohexanecarboxylic Acids | 1 | 2012 | 140 | 0.380 |
Why?
|
Cervical Vertebrae | 1 | 2018 | 982 | 0.380 |
Why?
|
Maternal Age | 1 | 2014 | 809 | 0.380 |
Why?
|
Placenta | 2 | 2017 | 1724 | 0.370 |
Why?
|
Pancreatic Diseases | 1 | 2013 | 353 | 0.360 |
Why?
|
Amines | 1 | 2012 | 280 | 0.360 |
Why?
|
Pregnancy Outcome | 8 | 2021 | 2959 | 0.350 |
Why?
|
Misoprostol | 3 | 2020 | 94 | 0.350 |
Why?
|
Diagnostic Errors | 1 | 2017 | 1282 | 0.340 |
Why?
|
Lasers | 1 | 2014 | 952 | 0.340 |
Why?
|
Growth Disorders | 2 | 2013 | 635 | 0.330 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2018 | 1903 | 0.320 |
Why?
|
Encephalocele | 2 | 2018 | 137 | 0.320 |
Why?
|
Nose | 1 | 2013 | 524 | 0.320 |
Why?
|
Urogenital Abnormalities | 1 | 2011 | 255 | 0.320 |
Why?
|
Bone Regeneration | 1 | 2012 | 445 | 0.310 |
Why?
|
Thalidomide | 3 | 2020 | 885 | 0.310 |
Why?
|
Societies, Medical | 1 | 2020 | 3955 | 0.300 |
Why?
|
Hypothyroidism | 1 | 2013 | 670 | 0.300 |
Why?
|
Hand | 3 | 2021 | 907 | 0.290 |
Why?
|
International Classification of Diseases | 2 | 2021 | 925 | 0.290 |
Why?
|
Genes, Homeobox | 1 | 2009 | 289 | 0.290 |
Why?
|
Autistic Disorder | 1 | 2017 | 1240 | 0.290 |
Why?
|
Pelvis | 1 | 2011 | 737 | 0.280 |
Why?
|
Heart Defects, Congenital | 3 | 2021 | 4713 | 0.280 |
Why?
|
Developmental Disabilities | 1 | 2016 | 1516 | 0.280 |
Why?
|
Uterine Neoplasms | 1 | 2016 | 1422 | 0.270 |
Why?
|
Kidney Diseases | 1 | 2018 | 2102 | 0.270 |
Why?
|
Facies | 2 | 2005 | 224 | 0.270 |
Why?
|
Mexican Americans | 1 | 2007 | 164 | 0.270 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2013 | 783 | 0.270 |
Why?
|
Mortality | 1 | 2018 | 2917 | 0.270 |
Why?
|
Cleft Palate | 1 | 2012 | 598 | 0.270 |
Why?
|
Vascular Diseases | 1 | 2014 | 1162 | 0.260 |
Why?
|
Child | 14 | 2024 | 80863 | 0.260 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2012 | 1140 | 0.260 |
Why?
|
Tretinoin | 1 | 2009 | 525 | 0.250 |
Why?
|
Pregnancy Trimester, First | 4 | 2017 | 918 | 0.250 |
Why?
|
Virilism | 1 | 2005 | 28 | 0.250 |
Why?
|
Phenotype | 7 | 2021 | 16712 | 0.240 |
Why?
|
Neurology | 1 | 2013 | 786 | 0.240 |
Why?
|
HIV Infections | 6 | 2021 | 17564 | 0.240 |
Why?
|
Metacarpophalangeal Joint | 2 | 2018 | 82 | 0.240 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2005 | 247 | 0.230 |
Why?
|
Vitamin K Deficiency Bleeding | 1 | 2004 | 9 | 0.230 |
Why?
|
Hernia, Diaphragmatic | 1 | 2005 | 244 | 0.230 |
Why?
|
Intelligence Tests | 2 | 2022 | 505 | 0.230 |
Why?
|
Adrenal Hyperplasia, Congenital | 1 | 2005 | 98 | 0.230 |
Why?
|
Gestational Age | 6 | 2021 | 3615 | 0.220 |
Why?
|
Oxazines | 3 | 2021 | 357 | 0.220 |
Why?
|
Duane Retraction Syndrome | 1 | 2004 | 59 | 0.220 |
Why?
|
Hemangioma | 1 | 2009 | 727 | 0.220 |
Why?
|
Preimplantation Diagnosis | 1 | 2005 | 143 | 0.210 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2018 | 3440 | 0.210 |
Why?
|
Substance Abuse, Intravenous | 1 | 2007 | 530 | 0.210 |
Why?
|
Prevalence | 9 | 2019 | 15880 | 0.210 |
Why?
|
Dermatoglyphics | 1 | 2002 | 21 | 0.210 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2005 | 640 | 0.210 |
Why?
|
Hand Deformities | 1 | 2002 | 16 | 0.210 |
Why?
|
Alcohol Dehydrogenase | 1 | 2002 | 113 | 0.200 |
Why?
|
Kidney | 1 | 2018 | 7064 | 0.200 |
Why?
|
Nails | 1 | 2024 | 298 | 0.200 |
Why?
|
Neonatal Screening | 2 | 2017 | 618 | 0.200 |
Why?
|
Fetal Development | 2 | 2018 | 771 | 0.200 |
Why?
|
Boston | 4 | 2018 | 9361 | 0.190 |
Why?
|
Child, Preschool | 9 | 2024 | 42623 | 0.190 |
Why?
|
Male | 34 | 2024 | 364781 | 0.190 |
Why?
|
Vitamin K | 1 | 2004 | 314 | 0.190 |
Why?
|
Genetics, Medical | 1 | 2024 | 334 | 0.180 |
Why?
|
North America | 2 | 2023 | 1292 | 0.180 |
Why?
|
Antifibrinolytic Agents | 1 | 2004 | 289 | 0.180 |
Why?
|
Pyridones | 3 | 2021 | 819 | 0.180 |
Why?
|
Mesoderm | 1 | 2004 | 679 | 0.180 |
Why?
|
Thumb | 1 | 2002 | 232 | 0.170 |
Why?
|
Pregnancy Complications, Infectious | 4 | 2021 | 2181 | 0.170 |
Why?
|
Autopsy | 1 | 2004 | 1013 | 0.170 |
Why?
|
Craniofacial Abnormalities | 2 | 2017 | 320 | 0.170 |
Why?
|
Ultrasonography | 3 | 2021 | 5995 | 0.160 |
Why?
|
Translocation, Genetic | 1 | 2005 | 1395 | 0.160 |
Why?
|
Cardiovascular Abnormalities | 1 | 2019 | 143 | 0.160 |
Why?
|
Hydranencephaly | 1 | 2018 | 5 | 0.150 |
Why?
|
Poland Syndrome | 1 | 2018 | 14 | 0.150 |
Why?
|
Medical Records | 3 | 2012 | 1413 | 0.140 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2009 | 3612 | 0.140 |
Why?
|
Massachusetts | 4 | 2017 | 8908 | 0.140 |
Why?
|
Hemoglobinopathies | 1 | 2018 | 101 | 0.140 |
Why?
|
Adult | 28 | 2021 | 223542 | 0.140 |
Why?
|
Metatarsal Bones | 1 | 2018 | 111 | 0.140 |
Why?
|
Benzoxazines | 1 | 2018 | 321 | 0.130 |
Why?
|
Brain Neoplasms | 1 | 2018 | 9182 | 0.130 |
Why?
|
Mice, Inbred C3H | 2 | 2009 | 916 | 0.130 |
Why?
|
Meningomyelocele | 1 | 2018 | 182 | 0.130 |
Why?
|
Obstetric Labor, Premature | 1 | 2017 | 273 | 0.130 |
Why?
|
Consanguinity | 1 | 2018 | 460 | 0.130 |
Why?
|
Piperazines | 3 | 2021 | 2546 | 0.120 |
Why?
|
Ultrasonography, Prenatal | 4 | 2021 | 1767 | 0.120 |
Why?
|
Cell Hypoxia | 1 | 2018 | 661 | 0.120 |
Why?
|
Chorionic Gonadotropin | 1 | 2017 | 458 | 0.120 |
Why?
|
Adenine | 1 | 2021 | 993 | 0.120 |
Why?
|
Zidovudine | 1 | 2017 | 625 | 0.120 |
Why?
|
Pedigree | 2 | 2018 | 4545 | 0.120 |
Why?
|
Incidental Findings | 1 | 2019 | 699 | 0.120 |
Why?
|
Head and Neck Neoplasms | 1 | 2009 | 2915 | 0.120 |
Why?
|
Infectious Disease Transmission, Vertical | 2 | 2021 | 1359 | 0.120 |
Why?
|
Cognition Disorders | 2 | 2007 | 3985 | 0.120 |
Why?
|
United States | 13 | 2022 | 73121 | 0.110 |
Why?
|
Reference Standards | 1 | 2018 | 1015 | 0.110 |
Why?
|
Analysis of Variance | 2 | 2016 | 6242 | 0.110 |
Why?
|
Karyotyping | 1 | 2016 | 1173 | 0.110 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2018 | 386 | 0.110 |
Why?
|
Foot | 1 | 2018 | 577 | 0.110 |
Why?
|
Cohort Studies | 7 | 2014 | 41797 | 0.110 |
Why?
|
Anti-HIV Agents | 2 | 2021 | 4567 | 0.110 |
Why?
|
Sex Distribution | 1 | 2018 | 2286 | 0.100 |
Why?
|
Canada | 2 | 2011 | 2143 | 0.100 |
Why?
|
Risk | 5 | 2017 | 9642 | 0.100 |
Why?
|
SEER Program | 1 | 2018 | 1476 | 0.100 |
Why?
|
Infant, Low Birth Weight | 1 | 2017 | 875 | 0.100 |
Why?
|
Isoxazoles | 1 | 2014 | 233 | 0.100 |
Why?
|
Elbow | 1 | 2012 | 130 | 0.090 |
Why?
|
Cephalometry | 1 | 2013 | 379 | 0.090 |
Why?
|
History, 21st Century | 2 | 2024 | 1575 | 0.090 |
Why?
|
Population Surveillance | 3 | 2019 | 2601 | 0.090 |
Why?
|
Diabetes Complications | 1 | 2018 | 1322 | 0.090 |
Why?
|
Botswana | 3 | 2019 | 1059 | 0.090 |
Why?
|
Heart Failure | 1 | 2015 | 11857 | 0.090 |
Why?
|
Drug Therapy, Combination | 3 | 2021 | 6320 | 0.090 |
Why?
|
Hungary | 1 | 2010 | 82 | 0.090 |
Why?
|
Prenatal Care | 3 | 2012 | 1159 | 0.090 |
Why?
|
Case-Control Studies | 4 | 2014 | 22293 | 0.090 |
Why?
|
Cartilage | 2 | 2012 | 808 | 0.080 |
Why?
|
Central Nervous System Neoplasms | 1 | 2018 | 928 | 0.080 |
Why?
|
Forearm | 1 | 2012 | 428 | 0.080 |
Why?
|
History, 20th Century | 2 | 2024 | 2772 | 0.080 |
Why?
|
Mouth Abnormalities | 1 | 2009 | 19 | 0.080 |
Why?
|
Bone and Bones | 3 | 2012 | 2589 | 0.080 |
Why?
|
Smoking | 2 | 2018 | 9099 | 0.080 |
Why?
|
Bone Development | 1 | 2012 | 473 | 0.080 |
Why?
|
Genotype | 1 | 2002 | 13047 | 0.070 |
Why?
|
Transcription Factors | 2 | 2005 | 12174 | 0.070 |
Why?
|
Adolescent | 7 | 2018 | 89168 | 0.070 |
Why?
|
Tobacco Smoke Pollution | 1 | 2013 | 828 | 0.070 |
Why?
|
Lip | 1 | 2009 | 198 | 0.070 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2011 | 495 | 0.070 |
Why?
|
Maternal Health Services | 1 | 2012 | 471 | 0.070 |
Why?
|
Mice, Inbred AKR | 1 | 2006 | 104 | 0.070 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2007 | 310 | 0.070 |
Why?
|
Genetic Diseases, Inborn | 1 | 2011 | 604 | 0.070 |
Why?
|
Texas | 1 | 2007 | 405 | 0.070 |
Why?
|
Chromosomal Instability | 1 | 2007 | 178 | 0.070 |
Why?
|
Testosterone | 1 | 2017 | 2493 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2009 | 10784 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2018 | 1876 | 0.070 |
Why?
|
Mouth | 1 | 2009 | 383 | 0.070 |
Why?
|
Odds Ratio | 2 | 2014 | 9687 | 0.060 |
Why?
|
Amniocentesis | 1 | 2005 | 116 | 0.060 |
Why?
|
Preconception Care | 1 | 2006 | 143 | 0.060 |
Why?
|
Nuchal Translucency Measurement | 1 | 2005 | 59 | 0.060 |
Why?
|
Logistic Models | 4 | 2014 | 13324 | 0.060 |
Why?
|
International Cooperation | 1 | 2011 | 1439 | 0.060 |
Why?
|
Retrospective Studies | 6 | 2017 | 81834 | 0.060 |
Why?
|
Body Patterning | 1 | 2009 | 633 | 0.060 |
Why?
|
Clonazepam | 1 | 2004 | 135 | 0.060 |
Why?
|
Religion | 1 | 2007 | 377 | 0.060 |
Why?
|
Incidence | 2 | 2018 | 21552 | 0.060 |
Why?
|
Reference Values | 1 | 2011 | 4941 | 0.060 |
Why?
|
Twins, Monozygotic | 1 | 2005 | 472 | 0.060 |
Why?
|
Diseases in Twins | 1 | 2005 | 447 | 0.050 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2013 | 1905 | 0.050 |
Why?
|
Review Literature as Topic | 1 | 2005 | 354 | 0.050 |
Why?
|
Syndrome | 3 | 2007 | 3278 | 0.050 |
Why?
|
State Health Plans | 1 | 2005 | 220 | 0.050 |
Why?
|
Mutation | 2 | 2005 | 30243 | 0.050 |
Why?
|
Facial Asymmetry | 1 | 2004 | 173 | 0.050 |
Why?
|
Hospitals, Urban | 1 | 2005 | 501 | 0.050 |
Why?
|
Ear Canal | 1 | 2004 | 149 | 0.050 |
Why?
|
Bone Diseases, Developmental | 1 | 2004 | 132 | 0.050 |
Why?
|
Linear Models | 1 | 2013 | 5880 | 0.050 |
Why?
|
Prospective Studies | 5 | 2019 | 54914 | 0.050 |
Why?
|
Occipital Bone | 1 | 2002 | 55 | 0.050 |
Why?
|
Learning | 1 | 2012 | 1762 | 0.050 |
Why?
|
Cefuroxime | 1 | 2002 | 23 | 0.050 |
Why?
|
Nova Scotia | 1 | 2022 | 34 | 0.050 |
Why?
|
United States Food and Drug Administration | 1 | 2011 | 1669 | 0.050 |
Why?
|
Folic Acid Antagonists | 1 | 2002 | 75 | 0.050 |
Why?
|
Antidepressive Agents | 1 | 2014 | 2913 | 0.050 |
Why?
|
Spine | 1 | 2009 | 1142 | 0.050 |
Why?
|
Dioxins | 1 | 2002 | 91 | 0.050 |
Why?
|
Fathers | 1 | 2004 | 377 | 0.050 |
Why?
|
National Health Programs | 1 | 2005 | 442 | 0.050 |
Why?
|
Terminology as Topic | 1 | 2009 | 1539 | 0.050 |
Why?
|
Depressive Disorder | 1 | 2014 | 3738 | 0.050 |
Why?
|
Siblings | 1 | 2005 | 829 | 0.050 |
Why?
|
Genetic Counseling | 1 | 2005 | 633 | 0.050 |
Why?
|
Age of Onset | 1 | 2008 | 3342 | 0.050 |
Why?
|
Perception | 1 | 2007 | 1207 | 0.050 |
Why?
|
Patient Care Planning | 1 | 2006 | 904 | 0.050 |
Why?
|
Alcohol Drinking | 2 | 2004 | 4052 | 0.040 |
Why?
|
Arm | 1 | 2003 | 590 | 0.040 |
Why?
|
Socioeconomic Factors | 2 | 2019 | 7863 | 0.040 |
Why?
|
Skull | 1 | 2004 | 832 | 0.040 |
Why?
|
Single-Blind Method | 1 | 2003 | 1585 | 0.040 |
Why?
|
Homeodomain Proteins | 1 | 2009 | 2430 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2018 | 5887 | 0.040 |
Why?
|
Intelligence | 1 | 2004 | 929 | 0.040 |
Why?
|
Mice, Inbred C57BL | 2 | 2009 | 22365 | 0.040 |
Why?
|
Abortion, Induced | 1 | 2004 | 475 | 0.040 |
Why?
|
Neovascularization, Pathologic | 1 | 2009 | 2643 | 0.040 |
Why?
|
Microcephaly | 1 | 2002 | 426 | 0.040 |
Why?
|
Aged, 80 and over | 1 | 2023 | 59680 | 0.040 |
Why?
|
Alanine | 1 | 2021 | 613 | 0.040 |
Why?
|
Risk Factors | 6 | 2013 | 74915 | 0.040 |
Why?
|
Heterozygote | 1 | 2005 | 2792 | 0.040 |
Why?
|
Risk Assessment | 2 | 2018 | 24311 | 0.040 |
Why?
|
Epidemiologic Methods | 1 | 2002 | 1337 | 0.040 |
Why?
|
Pediatrics | 1 | 2013 | 3622 | 0.040 |
Why?
|
Sexual Behavior | 1 | 2007 | 2200 | 0.040 |
Why?
|
Hypertension | 1 | 2018 | 8611 | 0.040 |
Why?
|
HIV Integrase Inhibitors | 1 | 2019 | 165 | 0.040 |
Why?
|
Alkynes | 1 | 2018 | 327 | 0.040 |
Why?
|
Electroencephalography | 1 | 2013 | 6309 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2006 | 20231 | 0.030 |
Why?
|
Fertilization in Vitro | 1 | 2005 | 1297 | 0.030 |
Why?
|
Hearing Loss | 1 | 2004 | 786 | 0.030 |
Why?
|
Observer Variation | 1 | 2003 | 2622 | 0.030 |
Why?
|
Cyclopropanes | 1 | 2018 | 437 | 0.030 |
Why?
|
Health Surveys | 1 | 2005 | 4056 | 0.030 |
Why?
|
Obesity | 1 | 2018 | 13065 | 0.030 |
Why?
|
Ischemia | 1 | 2003 | 1900 | 0.030 |
Why?
|
Physicians | 1 | 2013 | 4615 | 0.030 |
Why?
|
Infant, Small for Gestational Age | 1 | 2017 | 464 | 0.030 |
Why?
|
Radiography | 2 | 2003 | 6995 | 0.030 |
Why?
|
Cognition | 1 | 2012 | 7066 | 0.030 |
Why?
|
Warfarin | 1 | 2002 | 1493 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2002 | 1891 | 0.030 |
Why?
|
Animals | 3 | 2011 | 169418 | 0.030 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2014 | 433 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2005 | 4417 | 0.020 |
Why?
|
Hospitals | 1 | 2005 | 3906 | 0.020 |
Why?
|
Young Adult | 5 | 2018 | 60045 | 0.020 |
Why?
|
Alleles | 1 | 2002 | 6890 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2004 | 12096 | 0.020 |
Why?
|
Mice | 2 | 2009 | 82045 | 0.020 |
Why?
|
Infant, Premature | 1 | 2017 | 2124 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2005 | 9623 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2010 | 39430 | 0.020 |
Why?
|
Chromosome Banding | 1 | 2007 | 261 | 0.020 |
Why?
|
Education | 1 | 2010 | 536 | 0.020 |
Why?
|
Cross-Cultural Comparison | 1 | 2010 | 639 | 0.020 |
Why?
|
Dwarfism | 1 | 2007 | 137 | 0.020 |
Why?
|
Propensity Score | 1 | 2014 | 1971 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2007 | 26351 | 0.020 |
Why?
|
World Health Organization | 1 | 2012 | 1328 | 0.020 |
Why?
|
Substance-Related Disorders | 1 | 2002 | 4453 | 0.020 |
Why?
|
Hypertelorism | 1 | 2005 | 29 | 0.020 |
Why?
|
Epiglottis | 1 | 2005 | 81 | 0.020 |
Why?
|
Isotretinoin | 1 | 2006 | 134 | 0.010 |
Why?
|
Anthropometry | 1 | 2009 | 1343 | 0.010 |
Why?
|
Time Factors | 1 | 2005 | 40271 | 0.010 |
Why?
|
Europe | 1 | 2010 | 3439 | 0.010 |
Why?
|
Zinc Fingers | 1 | 2005 | 577 | 0.010 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2005 | 507 | 0.010 |
Why?
|
Epiphyses | 1 | 2002 | 191 | 0.010 |
Why?
|
Anti-Asthmatic Agents | 1 | 2006 | 578 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2007 | 2525 | 0.010 |
Why?
|
Pregnancy Trimester, Second | 1 | 2003 | 738 | 0.010 |
Why?
|
Radius | 1 | 2003 | 443 | 0.010 |
Why?
|
Databases, Factual | 1 | 2012 | 8081 | 0.010 |
Why?
|
Head | 1 | 2002 | 927 | 0.010 |
Why?
|
Skin | 1 | 2003 | 4520 | 0.010 |
Why?
|
DNA | 1 | 2003 | 7213 | 0.010 |
Why?
|
Asthma | 1 | 2006 | 6274 | 0.000 |
Why?
|
Algorithms | 1 | 2003 | 14158 | 0.000 |
Why?
|
Genetic Predisposition to Disease | 1 | 2003 | 18048 | 0.000 |
Why?
|
Middle Aged | 1 | 2014 | 223418 | 0.000 |
Why?
|